Avascular Necrosis of Bone
7
1
1
1
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
14.3%
1 terminated out of 7 trials
50.0%
-36.5% vs benchmark
14%
1 trials in Phase 3/4
100%
1 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (7)
Outcomes From Hyperbaric Oxygen (HBO2) Treatment for Emerging Indications
Marrow Cellution™ vs. Traditional BMA Harvest Project
Randomized Fixed Bearing vs Mobile Bearing Cruciate Retaining TKA
Autologous Bone Marrow Stem Cell Transplantation for Osteonecrosis in Sickle Cell Disease
Talar Avascular Necrosis: Surgical Angiogenesis vs. Core Decompression
Talar Avascular Necrosis: Surgical Angiogenesis vs. Core Decompression
Primary TKA Cruciate Retaining vs Cruciate Substituting With Rotating Platform Knee Prostheses